skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Details
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:062254/0888   Pages: 15
Recorded: 12/30/2022
Attorney Dkt #:324998-125
Conveyance: SECURITY INTEREST (SEE DOCUMENT FOR DETAILS).
Total properties: 72
1
Patent #:
7825138
Issue Dt:
11/02/2010
Application #:
11165598
Filing Dt:
06/22/2005
Publication #:
US20070004638
Pub Dt:
01/04/2007
Title:
CRYSTAL FORMS OF (3R)-1-(2-METHYLALANYL-D-TRYPTOPHYL)-3-(PHENYLMETHYL)-3-PIPERIDINECARBOXYLIC ACID 1,2,2-TRIMETHYLHYDRAZIDE
2
Patent #:
7947724
Issue Dt:
05/24/2011
Application #:
11186311
Filing Dt:
07/21/2005
Publication #:
US20060069114
Pub Dt:
03/30/2006
Title:
LIQUID PHARMACEUTICAL FORMULATIONS OF PALONOSETRON
3
Patent #:
7947725
Issue Dt:
05/24/2011
Application #:
11388268
Filing Dt:
03/24/2006
Publication #:
US20060167071
Pub Dt:
07/27/2006
Title:
LIQUID PHARMACEUTICAL FORMULATIONS OF PALONOSETRON
4
Patent #:
7960424
Issue Dt:
06/14/2011
Application #:
11388270
Filing Dt:
03/24/2006
Publication #:
US20060167073
Pub Dt:
07/27/2006
Title:
LIQUID PHARMACEUTICAL FORMULATIONS OF PALONOSETRON
5
Patent #:
8450375
Issue Dt:
05/28/2013
Application #:
11908531
Filing Dt:
09/13/2007
Publication #:
US20080194699
Pub Dt:
08/14/2008
Title:
STABILIZED COMPOSITIONS OF VOLATILE ALKYLATING AGENTS AND METHODS OF USING THEREOF
6
Patent #:
8501817
Issue Dt:
08/06/2013
Application #:
12401812
Filing Dt:
03/11/2009
Publication #:
US20100029783
Pub Dt:
02/04/2010
Title:
STABILIZED COMPOSITIONS OF ALKYLATING AGENTS AND METHODS OF USING SAME
7
Patent #:
7838564
Issue Dt:
11/23/2010
Application #:
12549258
Filing Dt:
08/27/2009
Publication #:
US20100041767
Pub Dt:
02/18/2010
Title:
STABILIZED COMPOSITIONS OF VOLATILE ALKYLATING AGENTS AND METHODS OF USING THEREOF
8
Patent #:
8501818
Issue Dt:
08/06/2013
Application #:
12687605
Filing Dt:
01/14/2010
Publication #:
US20100152300
Pub Dt:
06/17/2010
Title:
STABILIZED COMPOSITIONS OF ALKYLATING AGENTS AND METHODS OF USING SAME
9
Patent #:
8466173
Issue Dt:
06/18/2013
Application #:
12831009
Filing Dt:
07/06/2010
Publication #:
US20110003996
Pub Dt:
01/06/2011
Title:
CRYSTAL FORMS OF (3R)-1-(2-METHYLALANYL-D-TRYPTOPHYL)-3-(PHENYLMETHYL)-3-PIPERIDINECARBOXYLIC ACID 1,2,2-TRIMETHYLHYDRAZIDE
10
Patent #:
8501819
Issue Dt:
08/06/2013
Application #:
12948593
Filing Dt:
11/17/2010
Publication #:
US20110065803
Pub Dt:
03/17/2011
Title:
STABILIZED COMPOSITIONS OF VOLATILE ALKYLATING AGENTS AND METHODS OF USING THEREOF
11
Patent #:
8623826
Issue Dt:
01/07/2014
Application #:
13077462
Filing Dt:
03/31/2011
Publication #:
US20120064153
Pub Dt:
03/15/2012
Title:
Compositions and Methods for Treating Centrally Mediated Nausea and Vomiting
12
Patent #:
8518981
Issue Dt:
08/27/2013
Application #:
13087012
Filing Dt:
04/14/2011
Publication #:
US20110192493
Pub Dt:
08/11/2011
Title:
LIQUID PHARMACEUTICAL FORMULATIONS OF PALONOSETRON
13
Patent #:
8658797
Issue Dt:
02/25/2014
Application #:
13404165
Filing Dt:
02/24/2012
Publication #:
US20120220629
Pub Dt:
08/30/2012
Title:
ASYMMETRIC UREAS AND MEDICAL USES THEREOF
14
Patent #:
8426450
Issue Dt:
04/23/2013
Application #:
13478361
Filing Dt:
05/23/2012
Title:
SUBSTITUTED 4-PHENYL PYRIDINES HAVING ANTI-EMETIC EFFECT
15
Patent #:
8664278
Issue Dt:
03/04/2014
Application #:
13735710
Filing Dt:
01/07/2013
Publication #:
US20130310461
Pub Dt:
11/21/2013
Title:
STABILIZED COMPOSITIONS OF VOLATILE ALKYLATING AGENTS AND METHODS OF USING THEREOF
16
Patent #:
8895586
Issue Dt:
11/25/2014
Application #:
13864381
Filing Dt:
04/17/2013
Publication #:
US20130231315
Pub Dt:
09/05/2013
Title:
METHODS OF TREATING EMESIS
17
Patent #:
8598218
Issue Dt:
12/03/2013
Application #:
13901288
Filing Dt:
05/23/2013
Publication #:
US20130267553
Pub Dt:
10/10/2013
Title:
LIQUID PHARMACEUTICAL FORMULATIONS OF PALONOSETRON
18
Patent #:
8598219
Issue Dt:
12/03/2013
Application #:
13901437
Filing Dt:
05/23/2013
Publication #:
US20130261592
Pub Dt:
10/03/2013
Title:
LIQUID PHARMACEUTICAL FORMULATIONS OF PALONOSETRON
19
Patent #:
9173942
Issue Dt:
11/03/2015
Application #:
13901830
Filing Dt:
05/24/2013
Publication #:
US20130261149
Pub Dt:
10/03/2013
Title:
LIQUID PHARMACEUTICAL FORMULATIONS OF PALONOSETRON
20
Patent #:
8729094
Issue Dt:
05/20/2014
Application #:
13902132
Filing Dt:
05/24/2013
Publication #:
US20130261150
Pub Dt:
10/03/2013
Title:
LIQUID PHARMACEUTICAL FORMULATIONS OF PALONOSETRON
21
Patent #:
9066980
Issue Dt:
06/30/2015
Application #:
13902299
Filing Dt:
05/24/2013
Publication #:
US20130289065
Pub Dt:
10/31/2013
Title:
LIQUID PHARMACEUTICAL FORMULATIONS OF PALONOSETRON
22
Patent #:
8951969
Issue Dt:
02/10/2015
Application #:
14069885
Filing Dt:
11/01/2013
Publication #:
US20140193487
Pub Dt:
07/10/2014
Title:
COMPOSITIONS AND METHODS FOR TREATING CENTRALLY MEDIATED NAUSEA AND VOMITING
23
Patent #:
9186357
Issue Dt:
11/17/2015
Application #:
14069927
Filing Dt:
11/01/2013
Publication #:
US20140194395
Pub Dt:
07/10/2014
Title:
COMPOSITIONS AND METHODS FOR TREATING CENTRALLY MEDIATED NAUSEA AND VOMITING
24
Patent #:
9271975
Issue Dt:
03/01/2016
Application #:
14069970
Filing Dt:
11/01/2013
Publication #:
US20140194438
Pub Dt:
07/10/2014
Title:
COMPOSITIONS AND METHODS FOR TREATING CENTRALLY MEDIATED NAUSEA AND VOMITING
25
Patent #:
9308266
Issue Dt:
04/12/2016
Application #:
14070981
Filing Dt:
11/04/2013
Publication #:
US20140097114
Pub Dt:
04/10/2014
Title:
LIQUID PHARMACEUTICAL FORMULATIONS OF PALONOSETRON
26
Patent #:
9751836
Issue Dt:
09/05/2017
Application #:
14150360
Filing Dt:
01/08/2014
Publication #:
US20140121210
Pub Dt:
05/01/2014
Title:
ASYMMETRIC UREAS AND MEDICAL USES THEREOF
27
Patent #:
9382191
Issue Dt:
07/05/2016
Application #:
14153914
Filing Dt:
01/13/2014
Publication #:
US20140194526
Pub Dt:
07/10/2014
Title:
STABILIZED COMPOSITIONS OF VOLATILE ALKYLATING AGENTS AND METHODS OF USING THEREOF
28
Patent #:
9403772
Issue Dt:
08/02/2016
Application #:
14360991
Filing Dt:
05/28/2014
Publication #:
US20150011510
Pub Dt:
01/08/2015
Title:
4-(5-(2-(3,5-BIS(TRIFLUOROMETHYL)PHENYL)-N,2-DIMETHYLPROPANAMIDO)-4-(o-TOLYL)PYRIDIN-2-YL)-1-METHYL-1-((PHOSPHONOOXY)METHYL)PIPERAZIN-1-IUM AS A NEUROKININ RECEPTOR MODULATOR
29
Patent #:
9403867
Issue Dt:
08/02/2016
Application #:
14539318
Filing Dt:
11/12/2014
Publication #:
US20150072934
Pub Dt:
03/12/2015
Title:
METHODS OF PRODUCING ANAMORELIN HYDROCHLORIDE HAVING CONTROLLED CHLORIDE CONTENT
30
Patent #:
9125905
Issue Dt:
09/08/2015
Application #:
14597489
Filing Dt:
01/15/2015
Publication #:
US20150141454
Pub Dt:
05/21/2015
Title:
LIQUID PHARMACEUTICAL FORMULATIONS OF PALONOSETRON
31
Patent #:
9546157
Issue Dt:
01/17/2017
Application #:
14640551
Filing Dt:
03/06/2015
Publication #:
US20150252021
Pub Dt:
09/10/2015
Title:
ASYMMETRIC PIPERIDINYL-SUBSTITUTED UREAS AS MEDICINES
32
Patent #:
9439854
Issue Dt:
09/13/2016
Application #:
14793233
Filing Dt:
07/07/2015
Publication #:
US20150306032
Pub Dt:
10/29/2015
Title:
LIQUID PHARMACEUTICAL FORMULATIONS OF PALONOSETRON
33
Patent #:
9675600
Issue Dt:
06/13/2017
Application #:
14839038
Filing Dt:
08/28/2015
Publication #:
US20160067236
Pub Dt:
03/10/2016
Title:
MEDICAL TREATMENTS BASED ON ANAMORELIN
34
Patent #:
9457020
Issue Dt:
10/04/2016
Application #:
14855564
Filing Dt:
09/16/2015
Publication #:
US20160000773
Pub Dt:
01/07/2016
Title:
LIQUID PHARMACEUTICAL FORMULATIONS OF PALONOSETRON
35
Patent #:
9951016
Issue Dt:
04/24/2018
Application #:
14865370
Filing Dt:
09/25/2015
Publication #:
US20160090359
Pub Dt:
03/31/2016
Title:
Crystalline Forms of an NK-1 Antagonist
36
Patent #:
9975921
Issue Dt:
05/22/2018
Application #:
14927669
Filing Dt:
10/30/2015
Publication #:
US20160046667
Pub Dt:
02/18/2016
Title:
Crystal Forms of Anamorelin
37
Patent #:
9943515
Issue Dt:
04/17/2018
Application #:
15003327
Filing Dt:
01/21/2016
Publication #:
US20160136162
Pub Dt:
05/19/2016
Title:
COMPOSITIONS AND METHODS FOR TREATING CENTRALLY MEDIATED NAUSEA AND VOMITING
38
Patent #:
9981002
Issue Dt:
05/29/2018
Application #:
15135051
Filing Dt:
04/21/2016
Publication #:
US20160229889
Pub Dt:
08/11/2016
Title:
METHODS OF PRODUCING ANAMORELIN HYDROCHLORIDE HAVING CONTROLLED CHLORIDE CONTENT
39
Patent #:
9956261
Issue Dt:
05/01/2018
Application #:
15135107
Filing Dt:
04/21/2016
Publication #:
US20160237115
Pub Dt:
08/18/2016
Title:
METHODS OF PRODUCING ANAMORELIN HYDROCHLORIDE HAVING CONTROLLED CHLORIDE CONTENT
40
Patent #:
9872883
Issue Dt:
01/23/2018
Application #:
15135147
Filing Dt:
04/21/2016
Publication #:
US20160235804
Pub Dt:
08/18/2016
Title:
METHODS OF PRODUCING ANAMORELIN HYDROCHLORIDE HAVING CONTROLLED CHLORIDE CONTENT
41
Patent #:
9457021
Issue Dt:
10/04/2016
Application #:
15190019
Filing Dt:
06/22/2016
Publication #:
US20160296510
Pub Dt:
10/13/2016
Title:
LIQUID PHARMACEUTICAL FORMULATIONS OF PALONOSETRON
42
Patent #:
9908907
Issue Dt:
03/06/2018
Application #:
15194984
Filing Dt:
06/28/2016
Publication #:
US20170050993
Pub Dt:
02/23/2017
Title:
SUBSTITUTED PIPERAZINIUMS FOR THE TREATMENT OF EMESIS
43
Patent #:
10005803
Issue Dt:
06/26/2018
Application #:
15282016
Filing Dt:
09/30/2016
Publication #:
US20170096442
Pub Dt:
04/06/2017
Title:
Crystalline Forms of Fosnetupitant
44
Patent #:
9926337
Issue Dt:
03/27/2018
Application #:
15368362
Filing Dt:
12/02/2016
Publication #:
US20170145038
Pub Dt:
05/25/2017
Title:
SUBSTITUTED ASYMMETRIC UREAS AS MODULATORS OF GHRELIN RECEPTOR ACTIVITY
45
Patent #:
10501479
Issue Dt:
12/10/2019
Application #:
15464430
Filing Dt:
03/21/2017
Publication #:
US20170275301
Pub Dt:
09/28/2017
Title:
Benzenesulfonyl-Asymmetric Ureas and Medical Uses Thereof
46
Patent #:
10278964
Issue Dt:
05/07/2019
Application #:
15590025
Filing Dt:
05/09/2017
Publication #:
US20170296526
Pub Dt:
10/19/2017
Title:
MEDICAL TREATMENTS BASED ON ANAMORELIN
47
Patent #:
10624911
Issue Dt:
04/21/2020
Application #:
15611785
Filing Dt:
06/02/2017
Publication #:
US20170348335
Pub Dt:
12/07/2017
Title:
Physiologically Balanced Injectable Formulations of Fosnetupitant
48
Patent #:
10407390
Issue Dt:
09/10/2019
Application #:
15663761
Filing Dt:
07/30/2017
Publication #:
US20180044293
Pub Dt:
02/15/2018
Title:
ASYMMETRIC UREAS AND MEDICAL USES THEREOF
49
Patent #:
NONE
Issue Dt:
Application #:
15804804
Filing Dt:
11/06/2017
Publication #:
US20180125797
Pub Dt:
05/10/2018
Title:
METHODS FOR TREATING SKIN DISORDERS WITH A TOPICAL COMPOSITION OF BIS-(2-CHLOROETHYL)METHYLAMINE
50
Patent #:
10208073
Issue Dt:
02/19/2019
Application #:
15874325
Filing Dt:
01/18/2018
Publication #:
US20180194788
Pub Dt:
07/12/2018
Title:
SOLUTION COMPRISING THE CHLORIDE HYDROCHLORIDE SALT OF 4-(5-(2-(3,5-BIS(TRIFLUOROMETHYL)PHENYL)-N,2-DIMETHYLPROPANAMIDO)-4-(o-TOLYL)PYRIDIN-2-YL)-1-METHYL-1-((PHOSPHONOOXY)METHYL)PIPERAZIN-1-IUM (FOSNETUPITANT) AND PALONOSETRON HYDROCHLORIDE IN COMBINATION WITH DEXAMETHASONE AS A NEUROKININ RECEPTOR MODULATOR
51
Patent #:
10577384
Issue Dt:
03/03/2020
Application #:
15889589
Filing Dt:
02/06/2018
Publication #:
US20190062352
Pub Dt:
02/28/2019
Title:
SUBSTITUTED ASYMMETRIC UREAS AS MODULATORS OF GHRELIN RECEPTOR ACTIVITY
52
Patent #:
10233154
Issue Dt:
03/19/2019
Application #:
15918868
Filing Dt:
03/12/2018
Publication #:
US20180201581
Pub Dt:
07/19/2018
Title:
Crystalline Forms of an NK-1 Antagonist
53
Patent #:
10828297
Issue Dt:
11/10/2020
Application #:
15923050
Filing Dt:
03/16/2018
Publication #:
US20180256567
Pub Dt:
09/13/2018
Title:
COMPOSITIONS AND METHODS FOR TREATING CENTRALLY MEDIATED NAUSEA AND VOMITING
54
Patent #:
10300105
Issue Dt:
05/28/2019
Application #:
15963284
Filing Dt:
04/26/2018
Publication #:
US20190000914
Pub Dt:
01/03/2019
Title:
METHODS OF PRODUCING ANAMORELIN HYDROCHLORIDE HAVING CONTROLLED CHLORIDE CONTENT
55
Patent #:
10717721
Issue Dt:
07/21/2020
Application #:
16228835
Filing Dt:
12/21/2018
Publication #:
US20190177296
Pub Dt:
06/13/2019
Title:
SUBSTITUTED PIPERAZINIUMS FOR THE TREATMENT OF EMESIS
56
Patent #:
10676440
Issue Dt:
06/09/2020
Application #:
16259913
Filing Dt:
01/28/2019
Publication #:
US20190152915
Pub Dt:
05/23/2019
Title:
CRYSTALLINE FORMS OF AN NK-1 ANTAGONIST
57
Patent #:
10894041
Issue Dt:
01/19/2021
Application #:
16275669
Filing Dt:
02/14/2019
Publication #:
US20190175574
Pub Dt:
06/13/2019
Title:
MEDICAL TREATMENTS BASED ON ANAMORELIN
58
Patent #:
10576122
Issue Dt:
03/03/2020
Application #:
16383623
Filing Dt:
04/14/2019
Publication #:
US20190231843
Pub Dt:
08/01/2019
Title:
METHODS OF PRODUCING ANAMORELIN HYDROCHLORIDE HAVING CONTROLLED CHLORIDE CONTENT
59
Patent #:
10905737
Issue Dt:
02/02/2021
Application #:
16751836
Filing Dt:
01/24/2020
Publication #:
US20200276259
Pub Dt:
09/03/2020
Title:
METHODS OF PRODUCING ANAMORELIN HYDROCHLORIDE HAVING CONTROLLED CHLORIDE CONTENT
60
Patent #:
11299472
Issue Dt:
04/12/2022
Application #:
16767842
Filing Dt:
05/28/2020
Publication #:
US20200299260
Pub Dt:
09/24/2020
Title:
Fumarate Salt of (R)-3-(1-(2,3-dichloro-4-(pyrazin-2-yl)phenyl)-2,2,2-trifluoroethyl)-1-methyl-1-(1-methylpiperidin-4-yl) urea, Methods of Preparation, and Uses Thereof
61
Patent #:
11529362
Issue Dt:
12/20/2022
Application #:
16817683
Filing Dt:
03/13/2020
Publication #:
US20200206249
Pub Dt:
07/02/2020
Title:
PHYSIOLOGICALLY BALANCED INJECTABLE FORMULATIONS OF FOSNETUPITANT
62
Patent #:
10961195
Issue Dt:
03/30/2021
Application #:
16863038
Filing Dt:
04/30/2020
Publication #:
US20200255381
Pub Dt:
08/13/2020
Title:
CRYSTALLINE FORMS OF AN NK-1 ANTAGONIST
63
Patent #:
11312698
Issue Dt:
04/26/2022
Application #:
16896135
Filing Dt:
06/08/2020
Publication #:
US20200399240
Pub Dt:
12/24/2020
Title:
FOSNETUPITANT CHLORIDE HYDROCHLORIDE HAVING IMPROVED STABILITY
64
Patent #:
12005056
Issue Dt:
06/11/2024
Application #:
16982107
Filing Dt:
09/18/2020
Publication #:
US20230158007
Pub Dt:
05/25/2023
Title:
New Centrally-Active Ghrelin Agonist and Medical Uses Thereof
65
Patent #:
11559523
Issue Dt:
01/24/2023
Application #:
17075757
Filing Dt:
10/21/2020
Publication #:
US20210100794
Pub Dt:
04/08/2021
Title:
COMPOSITIONS AND METHODS FOR TREATING CENTRALLY MEDIATED NAUSEA AND VOMITING
66
Patent #:
11723902
Issue Dt:
08/15/2023
Application #:
17119482
Filing Dt:
12/11/2020
Publication #:
US20210093627
Pub Dt:
04/01/2021
Title:
MEDICAL TREATMENTS BASED ON ANAMORELIN
67
Patent #:
NONE
Issue Dt:
Application #:
17185206
Filing Dt:
02/25/2021
Publication #:
US20210269401
Pub Dt:
09/02/2021
Title:
CRYSTALLINE FORMS OF AN NK-1 ANTAGONIST
68
Patent #:
NONE
Issue Dt:
Application #:
17634616
Filing Dt:
02/11/2022
Publication #:
US20220323430
Pub Dt:
10/13/2022
Title:
METHODS OF MANUFACTURING ANAMORELIN TABLETS HAVING IMPROVED STABILITY
69
Patent #:
11884646
Issue Dt:
01/30/2024
Application #:
17688016
Filing Dt:
03/07/2022
Publication #:
US20220340541
Pub Dt:
10/27/2022
Title:
Fumarate Salt of (R)-3-(1-(2,3-dichloro-4-(pyrazin-2-yl)phenyl)-2,2,2-trifluoroethyl)-1-methyl-1-(1-methylpiperidin-4-yl)urea, Methods of Preparation, and Uses Thereof
70
Patent #:
NONE
Issue Dt:
Application #:
17699522
Filing Dt:
03/21/2022
Publication #:
US20220401463
Pub Dt:
12/22/2022
Title:
PROCESS FOR THE SYNTHESIS OF SUBSTITUTED CHLOROMETHYL DIALKYLPHOSPHATES
71
Patent #:
NONE
Issue Dt:
Application #:
17838308
Filing Dt:
06/13/2022
Publication #:
US20220401429
Pub Dt:
12/22/2022
Title:
USE OF ANAMORELIN TO TREAT CANCER-RELATED FATIGUE
72
Patent #:
NONE
Issue Dt:
Application #:
17986934
Filing Dt:
11/15/2022
Publication #:
US20230172953
Pub Dt:
06/08/2023
Title:
PHYSIOLOGICALLY BALANCED INJECTABLE FORMULATIONS OF FOSNETUPITANT
Assignors
1
HELSINN HEALTHCARE SA
Exec Dt:
12/30/2022
2
HELSINN THERAPEUTICS (U.S.), INC.
Exec Dt:
12/30/2022
3
HELSINN BIREX PHARMACEUTICALS LIMITED
Exec Dt:
12/30/2022
Assignee
1
HAMILTON SA LLC
C/O OBERLAND CAPITAL MANAGEMENT LLC, 1700 BROADWAY, 37TH FLOOR
NEW YORK, NEW YORK 10019
Correspondence name and address
JENNIFER GU C/O COOLEY LLP
3175 HANOVER STREET
PALO ALTO, CA 94304

Search Results as of: 06/18/2024 09:52 PM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT